Drug Shortage Report for SODIUM PHOSPHATES INJECTION USP
Report ID | 168559 |
Drug Identification Number | 00896187 |
Brand name | SODIUM PHOSPHATES INJECTION USP |
Common or Proper name | SODIUM PO4 |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | SODIUM PHOSPHATE DIBASIC SODIUM PHOSPHATE MONOBASIC |
Strength(s) | 268MG 276MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 10ML 10LIVI |
ATC code | B05XA |
ATC description | I.V. SOLUTION ADDITIVES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-02-20 |
Estimated end date | 2023-04-03 |
Actual end date | 2023-04-03 |
Shortage status | Resolved |
Updated date | 2023-04-06 |
Company comments | Baxter item : 7990 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v18 | 2023-04-06 | French | Compare |
v17 | 2023-04-06 | English | Compare |
v16 | 2023-03-23 | French | Compare |
v15 | 2023-03-23 | English | Compare |
v14 | 2023-02-16 | French | Compare |
v13 | 2023-02-16 | English | Compare |
v12 | 2023-02-14 | French | Compare |
v11 | 2023-02-14 | French | Compare |
v10 | 2023-02-14 | English | Compare |
v9 | 2023-01-27 | French | Compare |
v8 | 2023-01-27 | English | Compare |
v7 | 2022-12-16 | French | Compare |
v6 | 2022-12-16 | English | Compare |
v5 | 2022-12-15 | French | Compare |
v4 | 2022-12-15 | English | Compare |
v3 | 2022-09-03 | English | Compare |
v2 | 2022-09-02 | French | Compare |
v1 | 2022-09-02 | English | Compare |
Showing 1 to 18 of 18